Bottom Line:
📊 HOLD: PM is fairly valued with market pricing in 3.1% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)50% (Hyper Growth)
EST. PRICE IN 2031
$229.11
Based on 7.2% avg growth
INTRINSIC VALUE TODAY
$142.26
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.5x Exit PE.
Valuation Analysis: PM is currently trading at $179.44, which is considered extended relative to its 30-day fair value range of $159.32 to $174.00. The stock's valuation (Forward PE: 21.4) is in line with its historical norms (19.5). At these levels, the market is pricing in 3.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, PM is in a strong downtrend. The price is approaching resistance at $181.00. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PM has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$159.32 -
$174.00
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
PM is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI has not only diversified away from smokable products but also gained a toehold in the US to sell its Iqos heated tobacco product.